Although one cannot of course 100% guarantee financing because stuff happens that cannot be foreseen, but IMO the risk of not getting it is very very low.  Otherwise this would have all been over long before now. This company has been operating on a shoestring for some time because there really hasn't been anything to warrant major cash inflows after BoM failed to hit the mark. Yes, you can argue  management's seeming inability to promote things like the BTD or whatever but real money comes from having successful trials, and we simply haven't had that in a way that excites the market.

Covid trial aside, I suspect the market will start to wake up to RVX again once financing for BoM2 is announced and the trial is actually underway. That alone will probably push the SP back up to around $3 or so. Even CCD and fuzzyjr won't be able to resist getting back in.